Jubilant Ingrevia (JUBLINGREA) Q1 26/27 earnings summary

Executive summary

• Q1 FY27 delivered strong financial performance with consolidated revenue reaching ₹1,300 crore, up 25% year-over-year, and EBITDA up 37% year-over-year, marking a 15-quarter high and robust operational execution despite global supply chain disruptions.

• Growth was broad-based across Specialty Chemicals, Nutrition, and Chemical Intermediates, with Pharmaceuticals and Agrochemicals showing resilient demand and healthy export visibility.

• The company advanced strategic priorities, expanding its CDMO and fine chemicals pipeline, completed the integration of Remidex Pharma, and maintained global leadership in core products.

• Net profit for the quarter was ₹10,582 lakhs, up from ₹7,510 lakhs year-over-year and ₹8,644 lakhs sequentially.

• The company expanded its customer base, especially in electronics/semiconductor and cosmetics.

Financial highlights

• Revenue reached ₹1,300 crore, up 25% year-over-year and 10% sequentially; EBITDA at ₹209 crore, up 37% year-over-year and 22% quarter-on-quarter; PAT at ₹106 crore, up 41% year-over-year and 22% quarter-on-quarter.

• Specialty Chemicals revenue was ₹533 crore (+11% YoY), Nutrition & Health revenue ₹243 crore (+36% YoY), Chemical Intermediates revenue ₹524 crore (+38% YoY).

• EBITDA margin improved to 16%, PAT margin at 8%, and EPS was ₹6.7, up 41% YoY.

• Operating margin was 11.39% (up from 9.76% YoY); net profit margin improved to 8.07% from 7.16% YoY.

• Debt service coverage ratio stood at 4.81 times, and interest service coverage ratio at 12.01 times.

Outlook and guidance

• Sequential improvement in revenue and EBITDA expected in coming quarters, led by Specialty Chemicals and Nutrition, with recovery in acetyls.

• FY27 EBITDA guidance maintained at ₹750–800 crore, with first half expected to deliver ₹400+ crore.

• New multipurpose plant on track for commissioning by year-end, supporting CDMO and fine chemicals growth.

• The group is monitoring the impact of the newly notified Code of Wages (Central) Rules, 2026, and will update accounting as needed.